Health Care Weekly: Florida AG Accuses PBMs of Price-Fixing; Acquisitions of Pending Pharma IP Should Face Antitrust Scrutiny, FTC Says; FDA Targets Online Peptide Sellers; Medicare DME Moratorium Ends; Dialysis Giants Comment on ESRD Proposal; Update on FDA Warnings About Clinical Trial Disclosures
The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week...
Sep 02, 2026
Read Now >


